Long-Term Liabilities: The sum of all non-current liabilities.
Teva Pharmaceutical Industries Ltd. (TEVA) had Long-Term Liabilities of $19.38B for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$4.71B |
|
$481.00M |
|
$2.06B |
|
$2.65B |
|
$4.41B |
|
$300.00M |
|
$-220.00M |
|
$80.00M |
|
$80.00M |
|
$470.00M |
|
$482.00M |
|
$481.00M |
|
$470.00M |
|
$300.00M |
|
$560.00M |
|
1.15B |
|
1.16B |
|
$0.41 |
|
$0.42 |
|
| Balance Sheet Financials | |
$13.95B |
|
$4.08B |
|
$26.80B |
|
$40.75B |
|
$13.46B |
|
$14.99B |
|
|
Long-Term Liabilities |
$19.38B |
$32.83B |
|
$7.91B |
|
$-11.87B |
|
$7.91B |
|
1.15B |
|
| Cash Flow Statement Financials | |
$1.65B |
|
$737.00M |
|
$-2.15B |
|
$3.30B |
|
$3.56B |
|
$256.00M |
|
$157.00M |
|
$-340.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.04 |
|
-- |
|
-- |
|
0.65 |
|
2.12 |
|
56.36% |
|
6.37% |
|
6.37% |
|
-- |
|
1.70% |
|
10.21% |
|
$1.18B |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.65 |
|
1.27 |
|
70.86 |
|
6.09% |
|
-4.06% |
|
1.18% |
|
2.10% |
|
$6.88 |
|
$1.02 |
|
$1.42 |
|